Home / Import refusals / 1FX-2700396-0/30002/1

FDA Import Refusal 1FX-2700396-0/30002/1 — Daewoong Pharmaceutical, Co., Ltd.

Daewoong Pharmaceutical, Co., Ltd. — FEI 3011410400

The FDA refused shipment 1FX-2700396-0/30002/1 from Daewoong Pharmaceutical, Co., Ltd. (South Korea) on April 17, 2026. The refused product falls under Devices — IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE. Cited charges: 118,237,3280,508 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 17, 2026
Country
South Korea
Product Category
Devices
Product Code
79LMH IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
Charges
118,237,3280,508

Other import refusals

  • 1FX-6502672-5/10002/2 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Cosmetics)
  • 1FX-6936686-1/10002/2 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Cosmetics)
  • 1FX-7166691-0/20002/3 (Fri Jun 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Cosmetics)
  • 1FX-6805522-6/30002/1 (Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-2700396-0/20002/2 (Fri Apr 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources